The investigation spanned a total of 66 weeks from start to finish and the Authority identified several flaws in the ...

Novo Nordisk announced disappointing data from a phase III study on a novel obesity candidate, CagriSema. Roche announced a ...

More acne treatments have been recalled due to contamination with benzene—a known cancer-causing chemical.

Basel: Roche has announced that it has entered into an exclusive collaboration and licensing agreement with Zealand Pharma.

Amidst a backdrop of global trade policy uncertainty and mixed economic signals, the European market has shown resilience, with Germany's DAX Index rising by over 2% despite broader concerns impacting ...

The US Food and Drug Administration has recalled six skincare products from popular brands due to benzene contamination, which is linked to cancer risk. The FDA emphasised that the cancer risk to ...

Health-care companies fell, but not by as much as the broad market, as traders sought out defensive sectors. Drugmaker Mallinckrodt struck a deal to buy rival Endo, one of the drug makers driven into ...

Current health news highlights include Apollo Hospitals' AI investments to alleviate staff workload, Dr. Mehmet Oz's Medicare ...

AbbVie Inc. enters the obesity market with GUBamy, a promising amylin analog. Click here to find out why ABBV stock is a Buy.

Stocks entered a correction on Thursday as the S&P 500 index fell 10% from its recent peak after President Donald Trump escalated the trade war with 200% tariffs on European alcoholic beverages. This ...